This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopad [2023/10/03 07:51] – [XopAD] rkoebnik | bacteria:t3e:xopad [2025/02/13 13:33] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopAD ====== | + | ====== |
Author: [[https:// | Author: [[https:// | ||
Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
- | Expert reviewer: **WANTED!** | ||
Class: XopAD\\ | Class: XopAD\\ | ||
Line 25: | Line 24: | ||
No PIP box was found in the promoter region of //xopAD// in //X. euvesicatoria// | No PIP box was found in the promoter region of //xopAD// in //X. euvesicatoria// | ||
- | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//), including //xopAD//, were significantly reduced in the // | + | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//), including //xopAD//, were significantly reduced in the // |
=== Phenotypes === | === Phenotypes === | ||
Line 48: | Line 47: | ||
Yes. XopAD is homologous to members of the RipS1 family of effectors in //Ralstonia solanacearum// | Yes. XopAD is homologous to members of the RipS1 family of effectors in //Ralstonia solanacearum// | ||
- | |||
===== References ===== | ===== References ===== | ||
Line 68: | Line 66: | ||
White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||